Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma

Yu Lueng Shih, Rong Yuan Shyu, Chung Bao Hsieh, Hung Cheng Lai, Kuo Yu Liu, Tang Yuan Chu, Ya Wen Lin

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

BACKGROUND. The secreted frizzled-related protein 1 gene (SFRP1) encodes a Wnt/β-catenin signaling antagonist and frequently is inactivated by promoter methylation in many tumors. However, the role of SFRP1 in hepatocellular carcinoma (HCC) is not clear. Therefore, the authors investigated whether methylation of the SFRP1 promoter is common in HCC and whether it may influence SFRP1 expression. METHODS. Four HCC cell lines, 54 HCCs, 42 cirrhotic livers, 21 livers with chronic hepatitis, and 15 normal control tissues were analyzed for 1) SFRP1 promoter methylation by using methylation-specific polymerase chain reaction analysis and bisulfite sequencing, 2) SFRP1 messenger RNA expression by using quantitative reverse transcriptase-polymerase chain reaction analysis, and 3) loss of heterozygosity (LOH) by using microsatellite markers flanking the SFRP1 locus. HCC cells were treated with the demethylating agent 5-aza-2′-deoxycytidine to determine whether it could restore SFRP1 expression. RESULTS. SFRP1 promoter methylation was observed in 75%, 48.2%, 21.4%, 14.3% and 0% in HCC cell lines, primary HCCs, cirrhotic livers, livers with chronic hepatitis, and normal control tissues, respectively. Methylation of the SFRP1 promoter region in HCCs increased significantly compared with control tissues. All samples with SFRP1 methylation showed down-regulation of SFRP1 expression. Demethylation treatment with 5-aza-2′-deoxycytidine in HCC cells restored SFRP1 expression. Moreover, LOH of markers D8S505 and D8S1722 was found in 25% and 27.6% of the informative samples, respectively. CONCLUSIONS. The current results suggested that promoter hypermethylation of SFRP1 is a common event in HCC and plays an important role in the regulation of SFRP1 expression. In addition to methylation-mediated down-regulation of SFRP1, LOH also may play a role.

Original languageEnglish
Pages (from-to)579-590
Number of pages12
JournalCancer
Volume107
Issue number3
DOIs
Publication statusPublished - Aug 1 2006
Externally publishedYes

Fingerprint

Methylation
Hepatocellular Carcinoma
Genes
decitabine
Loss of Heterozygosity
Gene Expression
frizzled related protein-1
Liver
Chronic Hepatitis
Down-Regulation
Cell Line
Catenins
Reverse Transcriptase Polymerase Chain Reaction
Genetic Promoter Regions
Microsatellite Repeats

Keywords

  • Hepatocellular carcinoma
  • Loss of heterozygosity
  • Promoter hypermethylation
  • Secreted frizzled-related protein 1 gene

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. / Shih, Yu Lueng; Shyu, Rong Yuan; Hsieh, Chung Bao; Lai, Hung Cheng; Liu, Kuo Yu; Chu, Tang Yuan; Lin, Ya Wen.

In: Cancer, Vol. 107, No. 3, 01.08.2006, p. 579-590.

Research output: Contribution to journalArticle

Shih, Yu Lueng ; Shyu, Rong Yuan ; Hsieh, Chung Bao ; Lai, Hung Cheng ; Liu, Kuo Yu ; Chu, Tang Yuan ; Lin, Ya Wen. / Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. In: Cancer. 2006 ; Vol. 107, No. 3. pp. 579-590.
@article{ebf1c722edf744aab64126ee7f27eed4,
title = "Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma",
abstract = "BACKGROUND. The secreted frizzled-related protein 1 gene (SFRP1) encodes a Wnt/β-catenin signaling antagonist and frequently is inactivated by promoter methylation in many tumors. However, the role of SFRP1 in hepatocellular carcinoma (HCC) is not clear. Therefore, the authors investigated whether methylation of the SFRP1 promoter is common in HCC and whether it may influence SFRP1 expression. METHODS. Four HCC cell lines, 54 HCCs, 42 cirrhotic livers, 21 livers with chronic hepatitis, and 15 normal control tissues were analyzed for 1) SFRP1 promoter methylation by using methylation-specific polymerase chain reaction analysis and bisulfite sequencing, 2) SFRP1 messenger RNA expression by using quantitative reverse transcriptase-polymerase chain reaction analysis, and 3) loss of heterozygosity (LOH) by using microsatellite markers flanking the SFRP1 locus. HCC cells were treated with the demethylating agent 5-aza-2′-deoxycytidine to determine whether it could restore SFRP1 expression. RESULTS. SFRP1 promoter methylation was observed in 75{\%}, 48.2{\%}, 21.4{\%}, 14.3{\%} and 0{\%} in HCC cell lines, primary HCCs, cirrhotic livers, livers with chronic hepatitis, and normal control tissues, respectively. Methylation of the SFRP1 promoter region in HCCs increased significantly compared with control tissues. All samples with SFRP1 methylation showed down-regulation of SFRP1 expression. Demethylation treatment with 5-aza-2′-deoxycytidine in HCC cells restored SFRP1 expression. Moreover, LOH of markers D8S505 and D8S1722 was found in 25{\%} and 27.6{\%} of the informative samples, respectively. CONCLUSIONS. The current results suggested that promoter hypermethylation of SFRP1 is a common event in HCC and plays an important role in the regulation of SFRP1 expression. In addition to methylation-mediated down-regulation of SFRP1, LOH also may play a role.",
keywords = "Hepatocellular carcinoma, Loss of heterozygosity, Promoter hypermethylation, Secreted frizzled-related protein 1 gene",
author = "Shih, {Yu Lueng} and Shyu, {Rong Yuan} and Hsieh, {Chung Bao} and Lai, {Hung Cheng} and Liu, {Kuo Yu} and Chu, {Tang Yuan} and Lin, {Ya Wen}",
year = "2006",
month = "8",
day = "1",
doi = "10.1002/cncr.22023",
language = "English",
volume = "107",
pages = "579--590",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma

AU - Shih, Yu Lueng

AU - Shyu, Rong Yuan

AU - Hsieh, Chung Bao

AU - Lai, Hung Cheng

AU - Liu, Kuo Yu

AU - Chu, Tang Yuan

AU - Lin, Ya Wen

PY - 2006/8/1

Y1 - 2006/8/1

N2 - BACKGROUND. The secreted frizzled-related protein 1 gene (SFRP1) encodes a Wnt/β-catenin signaling antagonist and frequently is inactivated by promoter methylation in many tumors. However, the role of SFRP1 in hepatocellular carcinoma (HCC) is not clear. Therefore, the authors investigated whether methylation of the SFRP1 promoter is common in HCC and whether it may influence SFRP1 expression. METHODS. Four HCC cell lines, 54 HCCs, 42 cirrhotic livers, 21 livers with chronic hepatitis, and 15 normal control tissues were analyzed for 1) SFRP1 promoter methylation by using methylation-specific polymerase chain reaction analysis and bisulfite sequencing, 2) SFRP1 messenger RNA expression by using quantitative reverse transcriptase-polymerase chain reaction analysis, and 3) loss of heterozygosity (LOH) by using microsatellite markers flanking the SFRP1 locus. HCC cells were treated with the demethylating agent 5-aza-2′-deoxycytidine to determine whether it could restore SFRP1 expression. RESULTS. SFRP1 promoter methylation was observed in 75%, 48.2%, 21.4%, 14.3% and 0% in HCC cell lines, primary HCCs, cirrhotic livers, livers with chronic hepatitis, and normal control tissues, respectively. Methylation of the SFRP1 promoter region in HCCs increased significantly compared with control tissues. All samples with SFRP1 methylation showed down-regulation of SFRP1 expression. Demethylation treatment with 5-aza-2′-deoxycytidine in HCC cells restored SFRP1 expression. Moreover, LOH of markers D8S505 and D8S1722 was found in 25% and 27.6% of the informative samples, respectively. CONCLUSIONS. The current results suggested that promoter hypermethylation of SFRP1 is a common event in HCC and plays an important role in the regulation of SFRP1 expression. In addition to methylation-mediated down-regulation of SFRP1, LOH also may play a role.

AB - BACKGROUND. The secreted frizzled-related protein 1 gene (SFRP1) encodes a Wnt/β-catenin signaling antagonist and frequently is inactivated by promoter methylation in many tumors. However, the role of SFRP1 in hepatocellular carcinoma (HCC) is not clear. Therefore, the authors investigated whether methylation of the SFRP1 promoter is common in HCC and whether it may influence SFRP1 expression. METHODS. Four HCC cell lines, 54 HCCs, 42 cirrhotic livers, 21 livers with chronic hepatitis, and 15 normal control tissues were analyzed for 1) SFRP1 promoter methylation by using methylation-specific polymerase chain reaction analysis and bisulfite sequencing, 2) SFRP1 messenger RNA expression by using quantitative reverse transcriptase-polymerase chain reaction analysis, and 3) loss of heterozygosity (LOH) by using microsatellite markers flanking the SFRP1 locus. HCC cells were treated with the demethylating agent 5-aza-2′-deoxycytidine to determine whether it could restore SFRP1 expression. RESULTS. SFRP1 promoter methylation was observed in 75%, 48.2%, 21.4%, 14.3% and 0% in HCC cell lines, primary HCCs, cirrhotic livers, livers with chronic hepatitis, and normal control tissues, respectively. Methylation of the SFRP1 promoter region in HCCs increased significantly compared with control tissues. All samples with SFRP1 methylation showed down-regulation of SFRP1 expression. Demethylation treatment with 5-aza-2′-deoxycytidine in HCC cells restored SFRP1 expression. Moreover, LOH of markers D8S505 and D8S1722 was found in 25% and 27.6% of the informative samples, respectively. CONCLUSIONS. The current results suggested that promoter hypermethylation of SFRP1 is a common event in HCC and plays an important role in the regulation of SFRP1 expression. In addition to methylation-mediated down-regulation of SFRP1, LOH also may play a role.

KW - Hepatocellular carcinoma

KW - Loss of heterozygosity

KW - Promoter hypermethylation

KW - Secreted frizzled-related protein 1 gene

UR - http://www.scopus.com/inward/record.url?scp=33746296615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746296615&partnerID=8YFLogxK

U2 - 10.1002/cncr.22023

DO - 10.1002/cncr.22023

M3 - Article

VL - 107

SP - 579

EP - 590

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3

ER -